NEW YORK (360Dx) – Ceres Nanosciences said today it has signed an agreement with Netherlands-based Innatoss Laboratories to offer its Nanotrap Lyme Antigen Test to parts of the European Union.

Under the terms of the agreement, Innnatoss becomes the exclusive provider of the test in Austria, Belgium, France, Germany, Luxembourg, the Netherlands, Switzerland, and the United Kingdom, and will offer it as a laboratory-developed test.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.